Biotech
Avidia
New protein structural motifs for treating human disease.
Acquired by Amgen
(AMGN)
Calithera Biosciences
A new class of anti-cancer therapeutics based on activation of caspases
Catalyst Biosciences
Developer of engineered proteases as protein therapeutics that attack targets which cause disease.
PRIVATE
Elcelyx Therapeutics
Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity
FoldRx Pharmaceuticals
Treatments for diseases caused by misfolding of specific proteins
Acquired by Pfizer
Galleon Pharmaceuticals
Innovative medicines for pulmonology, neurology, cardiology, sleep medicine and pediatrics
PRIVATE
GlobeImmune
Therapeutic vaccine platform technology targeting infectious disease and cancer
PRIVATE
Morphotek, Inc.
Next generation antibodies production technology.
Acquired by EISIA
Mosaic Biosciences
Platform for tissue engineering using synthetic smart polymers
OncoMed Pharmaceuticals Inc.
Biological therapeutics targeting cancer stem cells
PRIVATE
Orexigen
Developer of drug treatments for obesity and related disorders.
(OREX)
Principia
Drug discovery company based on a proprietary chemistry platform that generates novel compounds with enhanced selectivity, high potency and longer duration of effect
Promedior Pharmaceuticals
Therapeutics to treat fibrosis
PRIVATE
Ra Pharmaceuticals
Platform for orally available and cell permeable biologics
Replidyne
Drug discovery and development focused on a new class of antibiotics
(RDYN)
Ribozyme Pharmaceuticals
RNA-based pharmaceuticals for human disease
(RZYM)
Stemgent
Reagents for stem cell researchers
PRIVATE
Threshold Pharmaceutical, Inc.
Developing targeted therapies for treatment of cancer.
(THLD)
Tragara Pharmaceuticals
Developer of drugs for the treatment of cancer and inflammation-related diseases.
PRIVATE
Trellis Bioscience
Platform technology for monoclonal antibody development and production
PRIVATE
Vical
DNA-based pharmaceuticals for human disease
(VICL)
